HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice-Reference-Cited by-同舟云学术

HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice

Published:2020-05-09 Issue:7 Volume:237 Page:2139-2149
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Sakloth Farhana,Manouras Lefteris,Avrampou Kleopatra,Mitsi Vasiliki,Serafini Randal A.,Pryce Kerri D.,Cogliani Valeria,Berton Olivier,Jarpe Matthew,Zachariou Venetia

Funder

National Institute of Neurological Disorders and Stroke

National Institute on Drug Abuse

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s00213-020-05525-9.pdf

Reference49 articles.

1. Alba-Delgado C, Llorca-Torralba M, Mico JA, Berrocoso E (2018) The onset of treatment with the antidepressant desipramine is critical for the emotional consequences of neuropathic pain. Pain 159:2606–2619. https://doi.org/10.1097/j.pain.0000000000001372

2. Avrampou K et al (2019) RGS4 maintains chronic pain symptoms in rodent models. J Neurosci. https://doi.org/10.1523/JNEUROSCI.3154-18.2019

3. Bai G, Wei D, Zou S, Ren K, Dubner R (2010) Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain 6:51. https://doi.org/10.1186/1744-8069-6-51

4. Benoy V, Vanden Berghe P, Jarpe M, Van Damme P, Robberecht W, Van Den Bosch L (2017) Development of improved HDAC6 inhibitors as pharmacological therapy for axonal charcot-marie-tooth disease. Neurotherapeutics 14:417–428. https://doi.org/10.1007/s13311-016-0501-z

5. Bohren Y et al (2010) Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia. Eur J Pain 14:700–704. https://doi.org/10.1016/j.ejpain.2009.11.014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleus accumbens myocyte enhancer factor 2C mediates the maintenance of peripheral nerve injury–induced physiological and behavioral maladaptations;Pain;2024-07-09

2. Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs;CNS Neuroscience & Therapeutics;2024-05

3. Histone deacetylase inhibitor decreases hyperalgesia in a mouse model of alcohol withdrawal‐induced hyperalgesia;Alcohol, Clinical and Experimental Research;2024-02-20

4. Histone deacetylase 6 deficiency protects the liver against ischemia/reperfusion injury by activating PI3K/AKT/mTOR signaling;The FASEB Journal;2024-02-09

5. Desipramine induces anti-inflammatory dorsal root ganglion transcriptional signatures in the murine spared nerve injury model;Neurobiology of Pain;2024-01